After an overdose of rapid‑acting insulin lispro (30 U) and a meal, the random blood glucose is 166 mg/dL at 2.5 hours post‑prandial; when should the next glucose check be performed?

When to Repeat Blood Glucose After Rapid‑Acting Insulin Overdose

Following a 30‑unit overdose of insulin lispro with a meal, repeat the blood glucose check in 1–2 hours (at approximately 3.5–4.5 hours post‑injection), then continue monitoring every 1–2 hours for at least 8–12 hours total, because lispro overdoses can cause recurrent hypoglycemia extending well beyond the drug's typical 3–5 hour duration.

---

Pharmacodynamic Profile of Insulin Lispro Overdose

• Insulin lispro reaches peak effect at approximately 1–3 hours after injection, with glucose‑lowering activity typically lasting 3–5 hours under normal therapeutic dosing 1.
• However, overdose fundamentally alters the duration of action: a documented case of 300 units lispro produced recurrent hypoglycemia requiring treatment for more than 11 hours, with the last episode occurring 11 hours post‑injection 2.
• At 2.5 hours post‑injection, the patient is approaching or at the peak insulin effect, meaning glucose may continue to decline even if currently 166 mg/dL 1, 2.

---

Immediate Monitoring Protocol

Next Glucose Check Timing

• Recheck glucose in 1–2 hours (at 3.5–4.5 hours post‑injection) to capture the tail end of peak insulin action and detect any downward trend 2.
• If glucose is stable or rising at 3.5–4.5 hours, continue checks every 2 hours until at least 8 hours post‑injection 2.
• If glucose is falling or <100 mg/dL at any point, escalate to hourly checks until a stable upward trend is confirmed 2.

Extended Monitoring Duration

• Continue glucose monitoring for a minimum of 8–12 hours after the overdose, because recurrent hypoglycemia can occur late even after initial stabilization 2.
• The plasma insulin level in the documented overdose case remained 1465 mU/L at 4 hours and did not normalize until 18 hours post‑injection 2.

---

Treatment Considerations During Monitoring

Glucose Infusion Strategy

• If the patient develops hypoglycemia (<70 mg/dL), treat with 15 g fast‑acting carbohydrate and recheck in 15 minutes 3.
• For recurrent or severe hypoglycemia, initiate continuous IV dextrose infusion (D10W at 40 mL/h or D5W at higher rates) to match the maximal glucose disposal rate induced by the overdose 2, 3.
• Do not rely solely on intermittent oral carbohydrate boluses in overdose situations, as they may be insufficient to prevent repeated hypoglycemic episodes 2.

Meal and Carbohydrate Timing

• The fact that a meal was consumed before the overdose provides some protection against immediate severe hypoglycemia, but does not eliminate the risk of late hypoglycemia as meal absorption completes and insulin action persists 4, 5.
• Encourage additional carbohydrate intake (15–30 g) at 4–6 hours post‑injection if glucose trends downward, even if not yet hypoglycemic 2.

---

Critical Pitfalls to Avoid

• Do not assume the patient is "safe" at 2.5 hours simply because glucose is 166 mg/dL; peak insulin effect is still occurring or imminent 1, 2.
• Do not discontinue monitoring at 5–6 hours even if glucose appears stable, because overdose cases demonstrate hypoglycemia extending to 11+ hours 2.
• Do not wait for symptoms of hypoglycemia to prompt glucose checks; asymptomatic hypoglycemia is common, and repeated episodes can cause hypoglycemia unawareness 3, 2.
• Never administer additional rapid‑acting insulin within 3–5 hours of the overdose, as "insulin stacking" will worsen hypoglycemia risk 6.

---

Escalation Criteria

• Seek immediate higher‑level care if:
  • Glucose falls <70 mg/dL despite oral carbohydrate treatment 3.
  • Recurrent hypoglycemia occurs (≥2 episodes requiring treatment) 2.
  • The patient develops altered mental status, seizures, or inability to take oral carbohydrates 3.
  • Glucose remains <100 mg/dL persistently despite intervention 2.

---

Evidence Strength Summary

• The recommendation for extended monitoring (8–12 hours) is based on a high‑quality case report documenting prolonged hypoglycemia after lispro overdose 2.
• The 1–2 hour recheck interval aligns with the known pharmacodynamic peak of lispro and the need to detect declining glucose before severe hypoglycemia develops 1, 2.
• The use of continuous IV dextrose for recurrent hypoglycemia is supported by both overdose case data and general hypoglycemia management guidelines 2, 3.